Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis

CA Cancer Journal for Clinicians

Volumn 65, Issue 3, 2015, Pages 239-251

  Violette, Philippe D ^a,b,c   Agoritsas, Thomas ^d   Alexander, Paul ^b   Riikonen, Jarno ^e   Santti, Henrikki ^f   Agarwal, Arnav ^b,g   Bhatnagar, Neera ^b   Dahm, Philipp ^h   Montori, Victor ⁱ   Guyatt, Gordon H ^b   Tikkinen, Kari A O ^f  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Woodstock General Hospital   (Canada)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ MAYO CLINIC   (United States)

Author keywords

decision making; decision support techniques; patient education as topic; patient participation; patient preference; patient satisfaction; prostatic neoplasms

Indexed keywords

BRACHYTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CLINICAL PRACTICE; CONSENSUS; CONSULTATION; COPING BEHAVIOR; DEMOGRAPHY; EMOTIONAL STABILITY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH IMPACT ASSESSMENT; HIGH RISK PATIENT; HUMAN; INTERPERSONAL COMMUNICATION; LOW RISK PATIENT; MEDICAL DECISION MAKING; MEDICAL EDUCATION; NORTH AMERICA; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; URINE INCONTINENCE; WATCHFUL WAITING; DECISION SUPPORT SYSTEM; MALE; META ANALYSIS; PROSTATIC NEOPLASMS; STATISTICAL MODEL;

DECISION SUPPORT TECHNIQUES; HUMANS; MALE; MODELS, STATISTICAL; PATIENT PARTICIPATION; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929131713     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21272     Document Type: Review

References (62)

1. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.
2. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005; 352: 1977-1984.
3. Bolla M, Gonzalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 1997; 337: 295-300.
4. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 2002; 360: 103-106.
5. Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370: 932-942.
6. Haskins AE, Han PK, Lucas FL, Bristol I, Hansen M,. Development of clinical models for predicting erectile function after localized prostate cancer treatment. Int J Urol. 2014; 21: 1227-1233.
7. Zhu Z, Zhang J, Liu Y, Chen M, Guo P, Li K,. Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis. Br J Cancer. 2014; 110: 2396-2404.
8. Jarosek SL, Virnig BA, Chu H, Elliott SP,. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both [published online ahead of print September 9, 2014]. Eur Urol. 2014.
9. Stattin P, Holmberg E, Johansson J-E, Holmberg L, Adolfsson J, Hugosson J,. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst. 2010; 102: 950-958.
10. Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. pt 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014; 65: 124-137.
11. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012; 367: 203-213.
12. Hayes JH, Ollendorf DA, Pearson SD, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010; 304: 2373-2380.
13. Weiner AB, Patel SG, Etzioni R, Eggener SE,. National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol. 2015; 193: 95-102.
14. Bergman J, Litwin MS,. Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr. 2012;2012: 242-249.
15. Venderbos LDF, van den Bergh RCN, Roobol MJ, et al. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels [published online ahead of print August 20, 2014]. Psychooncology. 2014.
16. Anderson J, Burney S, Brooker JE, et al. Anxiety in the management of localised prostate cancer by active surveillance. BJU Int. 2014; 114 (suppl): 55-61.
17. Jang TL, Bekelman JE, Liu Y, et al. Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med. 2010; 170: 440-450.
18. Xiong T, Turner RM, Wei Y, Neal DE, Lyratzopoulos G, Higgins JPT,. Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis [serial online]. BMJ Open 4: e004285, 2014.
19. Kon AA,. The shared decision-making continuum. JAMA. 2010; 304: 903-904.
20. Seaburg L, Hess EP, Coylewright M, Ting HH, McLeod CJ, Montori VM,. Shared decision making in atrial fibrillation: where we are and where we should be going. Circulation. 2014; 129: 704-710.
21. Gionfriddo MR, Leppin AL, Brito JP, et al. A systematic review of shared decision making interventions in chronic conditions: a review protocol [serial online]. Syst Rev. 2014; 3: 38.
22. Stacey D, Légaré F, Col NF, et al. Decision aids for people facing health treatment or screening decisions [serial online]. Cochrane Database Syst Rev. 2014; 1: CD001431.
23. Légaré F, Turcotte S, Stacey D, Ratté S, Kryworuchko J, Graham ID,. Patients' perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice. Patient. 2012; 5: 1-19.
24. Dwamena F, Holmes-Rovner M, Gaulden CM, et al. Interventions for providers to promote a patient-centered approach in clinical consultations [serial online]. Cochrane Database Syst Rev. 2012; 12: CD003267.
25. Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ,. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008; 77: 219-226.
26. Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010; 60: 70-98.
27. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013; 190: 419-426.
28. Stiggelbout AM, Van der Weijden T, De Wit MPT, et al. Shared decision making: really putting patients at the centre of healthcare [serial online]. BMJ. 2012; 344: e256.
29. Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF,. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology. 2007; 16: 543-552.
30. Feldman-Stewart D, Brundage MD, Siemens R, Skarsgard D,. A randomized controlled trial comparing two educational booklets on prostate cancer. Can J Urol. 2006; 13: 3321-3326.
31. Davison BJ, Goldenberg SL, Wiens KP, Gleave ME,. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer [serial online]. Cancer Nurs. 2007; 30: E7-E15.
32. Taylor KL, Davis KM, Lamond T, et al. Use and evaluation of a CD-ROM-based decision aid for prostate cancer treatment decisions. Behav Med. 2010; 36: 130-140.
33. Berry DL, Halpenny B, Hong F, et al. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol. 2013; 31: 1012-1021.
34. Feldman-Stewart D, Tong C, Siemens R, et al. The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making. 2012; 32: 616-626.
35. Hacking B, Wallace L, Scott S, Kosmala-Anderson J, Belkora J, McNeill A,. Testing the feasibility, acceptability and effectiveness of a "decision navigation" intervention for early stage prostate cancer patients in Scotland-a randomised controlled trial. Psychooncology. 2013; 22: 1017-1024.
36. Chabrera C, Zabalegui A, Bonet M, et al. A decision aid to support informed choices for patients recently diagnosed with prostate cancer: a randomized controlled trial [published online ahead of print July 9, 2014]. Cancer Nurs. 2014.
37. Chambers SK, Ferguson M, Gardiner RA, Aitken J, Occhipinti S,. Intervening to improve psychological outcomes for men with prostate cancer. Psychooncology. 2013; 22: 1025-1034.
38. Mishel MH, Germino BB, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009; 77: 349-359.
39. Diefenbach MA, Mohamed NE, Butz BP, et al. Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study [serial online]. J Med Internet Res. 2012; 14: e6.
40. van Tol-Geerdink JJ, Willem Leer J, Weijerman PC, et al. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid. BJU Int. 2013; 111: 564-573.
41. Davison BJ, Degner LF,. Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs. 1997; 20: 187-196.
42. Resources. Systematic Review and Literature Review Software from Evidence Partners [software program]. distillercer.com/resources/. Accessed October 9, 2014.
43. Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi) [serial online]. PLoS One. 2009; 4: e4705.
44. Thorlund K, Walter SD, Johnston BC, Furukawa TA, Guyatt GH,. Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods. 2011; 2: 188-203.
45. Guyatt GH, Thorlund K, Oxman AD, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013; 66: 173-183.
46. Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials [serial online]. BMJ. 2011; 343: d4002.
47. Higgins JPT, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558.
48. Marcus AC, Diefenbach MA, Stanton AL, et al. Cancer patient and survivor research from the Cancer Information Service Research Consortium: a preview of three large randomized trials and initial lessons learned. J Health Commun. 2013; 18: 543-562.
49. Auvinen A, Hakama M, Ala-Opas M, et al. A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen. BJU Int. 2004; 93: 52-56; discussion 56.
50. Berry DL, Wang Q, Halpenny B, Hong F,. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Educ Couns. 2012; 88: 262-267.
51. O'Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998; 33: 267-279.
52. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA,. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009; 59: 379-390.
53. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the equality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011; 64: 407-415.
54. Montori VM, LeBlanc A, Buchholz A, Stilwell DL, Tsapas A,. Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards [serial online]. BMC Med Inform Decis Mak. 2013; 13 (suppl 2): S5.
55. Van der Weijden T, Boivin A, Burgers J, Schünemann HJ, Elwyn G,. Clinical practice guidelines and patient decision aids. An inevitable relationship. J Clin Epidemiol. 2012; 65: 584-589.
56. Agoritsas T, Fog Heen A, Brandt L, et al. Decision aids that really promote shared decision making: the pace quickens [serial online]. BMJ. 2015; 350: g7624.
57. Vandvik PO, Brandt L, Alonso-Coello P, et al. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest. 2013; 144: 381-389.
58. Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM,. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making. 2010; 30: 701-711.
59. Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009; 169: 1560-1568.
60. Wyatt KD, Branda ME, Anderson RT, et al. Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters [serial online]. Implement Sci. 2014; 9: 26.
61. Légaré F, Stacey D, Turcotte S, et al. Interventions for improving the adoption of shared decision making by healthcare professionals [serial online]. Cochrane Database Syst Rev. 2014; 9: CD006732.
62. Montori VM, Breslin M, Maleska M, Weymiller AJ,. Creating a conversation: insights from the development of a decision aid [serial online]. PLoS Med. 2007; 4: e233.